Oh Sung Yong, Kwon Hyuk-Chan, Kim Sung-Hyun, Jang Jin Seok, Kim Min Chan, Kim Kyeong Hee, Han Jin-Yeong, Kim Chung Ock, Kim Su-Jin, Jeong Jin-sook, Kim Hyo-Jin
Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea.
BMC Cancer. 2008 May 1;8:123. doi: 10.1186/1471-2407-8-123.
Hypoxia influences tumor growth by inducing angiogenesis and genetic alterations. Hypoxia-inducible factor 1alpha (HIF-1alpha), p53, and vascular endothelial growth factor (VEGF) are all important factors in the mechanisms inherent to tumor progression. In this work, we have investigated the clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF (sVEGF) level in gastric cancer.We immunohistochemically assessed the HIF-1alpha, p53, and VEGF expression patterns in 114 specimens of gastric cancer. Additionally, we determined the levels of preoperative serum VEGF (sVEGF).
The positive rates of p53 and HIF-1alpha (diffuse, deep, intravascular pattern) were 38.6% and 15.8%, respectively. The VEGF overexpression rate was 57.9%. p53 and HIF-1alpha were correlated positively with the depth of invasion (P = 0.015, P = 0.001, respectively). Preoperative sVEGF and p53 levels were correlated significantly with lymph node involvement (P = 0.010, P = 0.040, respectively). VEGF overexpression was more frequently observed in the old age group (> or = 60 years old) and the intestinal type (P = 0.013, P = 0.014, respectively). However, correlations between preoperative sVEGF level and tissue HIF-1alpha, VEGF, and p53 were not observed. The median follow-up duration after operation was 24.5 months. HIF-1alpha was observed to be a poor prognostic factor of disease recurrence or progression (P = 0.002).
p53, HIF-1alpha and preoperative sVEGF might be markers of depth of invasion or lymph node involvement. HIF-1alpha expression was a poor prognostic factor of disease recurrence or progression in patients with gastric cancers.
缺氧通过诱导血管生成和基因改变影响肿瘤生长。缺氧诱导因子1α(HIF-1α)、p53和血管内皮生长因子(VEGF)都是肿瘤进展内在机制中的重要因素。在本研究中,我们调查了HIF-1α、p53和VEGF表达以及术前血清VEGF(sVEGF)水平在胃癌中的临床病理意义。我们采用免疫组织化学方法评估了114例胃癌标本中HIF-1α、p53和VEGF的表达模式。此外,我们还测定了术前血清VEGF(sVEGF)水平。
p53和HIF-1α(弥漫性、深层、血管内模式)的阳性率分别为38.6%和15.8%。VEGF过表达率为57.9%。p53和HIF-1α与浸润深度呈正相关(分别为P = 0.015,P = 0.001)。术前sVEGF和p53水平与淋巴结受累显著相关(分别为P = 0.010,P = 0.040)。VEGF过表达在老年组(≥60岁)和肠型中更常见(分别为P = 0.013,P = 0.014)。然而,未观察到术前sVEGF水平与组织HIF-1α、VEGF和p53之间的相关性。术后中位随访时间为24.5个月。HIF-1α被认为是疾病复发或进展的不良预后因素(P = 0.002)。
p53、HIF-1α和术前sVEGF可能是浸润深度或淋巴结受累的标志物。HIF-1α表达是胃癌患者疾病复发或进展的不良预后因素。